CSPC2016 has ended
Back To Schedule
Wednesday, November 9 • 10:30 - 12:00
Driving Innovation: the role of Canada’s stem cell & regenerative medicine sector / Impulser l'innovation : le rôle du Canada dans le domaine de la médecine régénérative et des cellules souches

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Organized by Stem Cell Network, Cate Murray

Health Innovation is a critical component for any nation’s innovation strategy. In Canada, health innovation is of paramount importance for the sustainability of our health system and for improving the health and well-being of Canadians. Of the $190 billion spent annually on chronic diseases, such as diabetes, heart disease, multiple sclerosis and cancer, approximately $68 billion is directly attributed to treatment expenditures. Stem Cell therapies and regenerative medicine promise to more effectively treat many of these debilitating conditions. Despite the relatively early stage of maturity, the market for therapies and treatments derived by these fields is growing and expected to surpass $20 billion U.S. by 2025.

Stem cell research and regenerative medicine are health innovation winners.  S&T experts agree that stem cell research, tissue engineering, and regenerative medicine are within the top three emerging research areas, and Canadian research strength is exceptional.  The proposed CSPC session will bring together key sector leaders who will address where the field is going, how Canada can secure its global strength, and the role & responsibilities of health innovation actors (i.e. industry, government, academia and civil society). Attention will also focus on translational research, commercialization, and support of both academics and industry in moving the best research to market and into the clinic.

avatar for Paul Wells

Paul Wells

National Affairs Columnist, Toronto Star
Paul Wells is a national affairs columnist at the Toronto Star. Previously, Wells was the political editor of Maclean's magazine. In 13 years at Maclean's, he won three gold National Magazine Awards. He moderated last year's Maclean's national leaders' debate, which drew more viewers... Read More →

avatar for Sharon Colle

Sharon Colle

President & CEO, Foundation Fighting Blindness
Ms. Sharon Colle, President and CEO, Foundation Fighting BlindnessChair, Board of Directors, Ontario Institute for Regenerative Medicine Sharon was the recipient of the 2013 Health Charity Coalition of Canada (HCCC) Award of Distinction as an outstanding contributor to the charitable... Read More →
avatar for Michael May

Michael May

President & CEO, Centre for Commercialization of Regenerative Medicine
Michael May is President and Chief Executive Officer of the Centre for Commercialization of Regenerative Medicine (CCRM), a Canadian, not-for-profit that develops technologies and launches new companies by supporting both academic and industry activities in the field of regenerative... Read More →
avatar for Lauralyn McIntyre

Lauralyn McIntyre

Senior Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute
Dr. Lauralyn McIntyre is an Intensivist at the Ottawa Hospital, Associate Professor in the Department of Medicine at the University of Ottawa and a Scientist with the Clinical Epidemiology Program at the Ottawa Hospital Research Institute. She is the ICU Research Chair at the Ottawa... Read More →
avatar for Michael Rudnicki

Michael Rudnicki

Scientific Director, Canadian Stem Cell Network.
Dr. Michael Rudnicki is a Senior Scientist and the Director of the Regenerative Medicine Program and the Sprott Centre for Stem Cell Research at the Ottawa Hospital Research Institute. He is a Professor in the Department of Medicine at the University of Ottawa. Dr. Rudnicki is the... Read More →

Wednesday November 9, 2016 10:30 - 12:00 EST
Room 209